Vendas Alterar Data
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Alterity Therapeutics Limited AUD 596.04K 584.66K 2025-12
Cara Therapeutics USD 2.57M 1.11M 2025-03
Chugai Pharma JPY 404.7B 63.1B 2026-09
Cipla INR 74.04B 2.85B 2026-09
Clal Biotechnology ILS 3.41M 2M 2022-12
Compugen USD 2.6M 3.75M 2026-06
CSL USD 8.33B 4.79B 2025-12
Grifols EUR 2B 306.7M 2026-03
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
J&J USD 25.4B 89M 2026-09
Neurocrine Biosciences USD 1.12B 161M 2026-09
Pacira USD 176.65M 15.75M 2026-09
Pfizer USD 16.6B 1.57B 2026-09
RedHill Biopharma USD 1.29M 722K 2024-06
Supernus Pharmaceuticals USD 226.8M 7.7M 2026-09
Vanda Pharmaceuticals USD 198.77M 151.12M 2024-12